scispace - formally typeset
M

Michael Karin

Researcher at University of California, San Diego

Publications -  753
Citations -  246120

Michael Karin is an academic researcher from University of California, San Diego. The author has contributed to research in topics: IκB kinase & Signal transduction. The author has an hindex of 236, co-authored 704 publications receiving 226485 citations. Previous affiliations of Michael Karin include Sanford-Burnham Institute for Medical Research & University of California, Los Angeles.

Papers
More filters

NF-kB as a Critical Link Between Inflammation and Cancer

TL;DR: Through its ability to up-regulate the expression of tumor promoting cytokines, such as IL-6 or TNF-a, and survival genes,such as Bcl-XL, NF-kB provides a critical link between inflammation and cancer.
Journal ArticleDOI

Loss of Ikkβ Promotes Migration and Proliferation of Mouse Embryo Fibroblast Cells

TL;DR: The data presented indicate that generation of ROS played a key role in the morphological and mobility changes in Ikkβ-/- cells, and suggest that IKKβ provides inhibitory signals for cell mobility and growth.
Journal Article

Conditional Deletion of IkappaB-Kinase-beta Accelerates Helicobacter-Dependent Gastric Apoptosis, Proliferation, and Preneoplasia

TL;DR: The loss of IKKbeta/NF-kappaB signaling in GECs results in increased apoptosis and necrosis in response to cellular stress, and accelerated development of dysplasia by Helicobacter infection.
Journal ArticleDOI

Cell-Selective Inhibition of NF-κB Signaling Improves Therapeutic Index in a Melanoma Chemotherapy Model

TL;DR: The findings show that the IκB kinase–NF-κB signaling pathway is important for both promoting treatment resistance and preventing host toxicity in cancer chemotherapy; however, the two functions are exerted by distinct cell type–specific mechanisms and can therefore be selectively targeted to achieve an improved therapeutic outcome.